Menlo Therapeutics OverviewMenlo Therapeutics Other Income Expense Net
Other Income/Expense Net for MNLO.
Quarterly Other Income/Expense
-$1.22M
↓ 314.01% YoY
As of Sep 30, 2020
Annual Other Income/Expense (TTM)
-$140.73M
↓ 4865.56% YoY
Trailing 12 months ending Sep 30, 2020